(Q33646840)

28 July 2017

1 reference

title

The threat of vancomycin resistance (English)

1 reference

28 July 2017

1 reference

Perl TM

1

1 reference

PubMed ID

10348061

28 July 2017

language of work or name

English

0 references

publication date

1 May 1999

1 reference

American Journal of Medicine

28 July 2017

1 reference

28 July 2017

106

1 reference

28 July 2017

5A

1 reference

28 July 2017

26S-37S; discussion 48S-52S

1 reference

Vancomycin-resistant enterococcal bacteremia: natural history and attributable mortality

28 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900354-4

Vancomycin-resistant enterococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900354-4

Vancomycin-resistant enterococci: clinical, microbiologic, and epidemiologic features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900354-4

Urinary tract infection with an Enterococcus faecalis isolate that requires vancomycin for growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900354-4

Emergence of vancomycin resistance in coagulase-negative staphylococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900354-4

Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900354-4

The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900354-4

Medical consequences of antibiotic use in agriculture.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900354-4

Emerging antibiotic resistance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900354-4

Diversity among multidrug-resistant enterococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900354-4

Vancomycin-resistant enterococci from nosocomial, community, and animal sources in the United States.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900354-4

Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900354-4

Nosocomial enterococcal blood stream infections in the SCOPE program: Antimicrobial resistance, species occurrence, molecular testing results, and laboratory testing accuracy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900354-4

Vancomycin-resistant Enterococcus faecium on a pediatric oncology ward: duration of stool shedding and incidence of clinical infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900354-4

Control of a nosocomial outbreak of vancomycin resistant Enterococcus faecium in a paediatric oncology unit: risk factors for colonisation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900354-4

Household transmission of vancomycin-resistant Enterococcus faecium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900354-4

Epidemiology of colonisation of patients and environment with vancomycin-resistant enterococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900354-4

Vancomycin-resistant enterococci in turkeys and farmers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900354-4

Farm animals as a putative reservoir for vancomycin-resistant enterococcal infection in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900354-4

Epidemiology of vancomycin-resistant enterococci in the community and the relevance of farm animals to human infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900354-4

Are glycopeptide-resistant enterococci in animals a threat to human beings?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900354-4

A semiquantitative analysis of the fecal flora of patients with vancomycin-resistant enterococci: colonized patients pose an infection control risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900354-4

Enterococcal bacteremia in the surgical intensive care unit. Does vancomycin resistance affect mortality? The Johns Hopkins SICU Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900354-4

Nosocomial infections with vancomycin-resistant Enterococcus faecium in liver transplant recipients: risk factors for acquisition and mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900354-4

Vancomycin-resistant enterococcus. Detection, epidemiology, and control measures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900354-4

Multiple-Antibiotic-Resistant Pathogenic Bacteria -- A Report on the Rockefeller University Workshop

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900354-4

The epidemiology of intravenous vancomycin usage in a university hospital. A 10-year study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900354-4

Limiting vancomycin use to combat vancomycin-resistant Enterococcus faecium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900354-4

Impact of a vancomycin restriction policy on use and cost of vancomycin and incidence of vancomycin-resistant Enterococcus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900354-4

Order form for restricting vancomycin prescribing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900354-4

Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900354-4

Experience with a hospital-wide outbreak of vancomycin-resistant enterococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900354-4

Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900354-4

First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospital

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900354-4

Effectiveness of contact isolation during a hospital outbreak of methicillin-resistant Staphylococcus aureus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900354-4

Vancomycin-resistant Staphylococcus aureus: perspectives on measures needed for control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900354-4

New approaches to reduce Staphylococcus aureus nosocomial infection rates: treating S. aureus nasal carriage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900354-4

Vancomycin-resistant enterococci outside the health-care setting: prevalence, sources, and public health implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900354-4

Isolation of vancomycin-resistant enterococci from supermarket poultry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900354-4

10.1016/S0002-9343(98)00354-4

7 January 2021

Identifiers

DOI

1 reference

28 July 2017

1 reference

PubMed ID

10348061